dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse

This website has run out of funding so feel free to contribute if you can afford it (see footer)

Author Topic: Dysregulation of the Endogenous Opioids for Psych Disorders (intro. Nalmefene)  (Read 1286 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6509
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:October 20, 2021, 05:43:37 AM
  • Deeply Confused Learner
  • Profession: IT Engineer
source: https://www.ncbi.nlm.nih.gov/pubmed/26250442

Abstract

Around half the inmates in prison institutions have antisocial personality disorder (ASPD). A recent theory has proposed that a dysfunction of the endogenous opioid system (EOS) underlies the neurobiology of borderline personality disorder (BPD).

In the present theoretical paper, based on a comprehensive database and hand search of the relevant literature, this hypothesis is extended to ASPD, which may be the predominant expression of EOS dysfunction in men, while the same pathology underlies BPD in women. According to evidence from human and animal studies, the problematic behaviours of persons with antisocial, callous, or psychopathic traits may be seen as desperate, unconscious attempts to stimulate their deficient EOS, which plays a key role in brain reward circuits.

If the needs of this system are not being met, the affected persons experience dysphoric mood, discomfort, or irritability, and strive to increase binding of endogenous opioids to receptors by using the rewarding effects of aggression by exertion of physical or manipulative power on others, by abusing alcohol or substances that have the reward system as target, by creating an "endorphin rush" by self-harm, by increasing the frequency of their sexual contacts, or by impulsive actions and sensation seeking. Symptoms associated with ASPD can be treated with opioid antagonists like naltrexone, naloxone, or nalmefeneWiki.
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
I do not condone or support any illegal activities. All information is for theoretical discussion and wonder.
All activities discussed are considered fictional and hypothetical. Information of all discussion has been derived from online research and in the spirit of personal Freedom.

Tags:
 

Related Topics

  Subject / Started by Replies Last post
4 Replies
3866 Views
Last post August 08, 2015, 02:23:50 PM
by Roman Totale
2 Replies
3225 Views
Last post August 16, 2015, 09:14:12 AM
by Narkotikon
2 Replies
2646 Views
Last post June 03, 2018, 06:24:34 AM
by limerence
0 Replies
1390 Views
Last post December 16, 2018, 07:35:34 PM
by Chip
0 Replies
1339 Views
Last post May 04, 2019, 02:56:04 PM
by Chip
0 Replies
1415 Views
Last post May 05, 2019, 07:48:33 AM
by Chip
1 Replies
1641 Views
Last post May 06, 2019, 05:24:02 AM
by MoeMentim
0 Replies
1111 Views
Last post May 29, 2019, 07:25:34 AM
by Chip
0 Replies
1297 Views
Last post July 03, 2019, 04:38:04 PM
by Chip
0 Replies
2506 Views
Last post March 28, 2020, 06:17:41 AM
by Chip


dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE


Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal